<?xml version="1.0" encoding="UTF-8"?>
<p>Cancer has been identified as a major public health problem globally. In the United states, cancer is one of the leading causes of mortality [
 <xref rid="B1-molecules-25-04435" ref-type="bibr">1</xref>]. In Sub-Saharan Africa, prostate, breast, and cervical cancers are the most common with high incidence rates. The occurrence of these cancers in Sub-Saharan Africa is estimated to double up in next 20 years [
 <xref rid="B2-molecules-25-04435" ref-type="bibr">2</xref>]. The cancer incidence rate is estimated to increase 50% by 2030; the burden is mostly expected to increase in low- and middle-income countries [
 <xref rid="B3-molecules-25-04435" ref-type="bibr">3</xref>]. The incidence and mortality rate of cancer in low- and middle-income countries are significantly increasing, and Zambia is of no exception [
 <xref rid="B4-molecules-25-04435" ref-type="bibr">4</xref>]. In South Africa, the incidence rate and treatment options of lung cancer differ between provinces because the country is diverse in terms of culture and racial groups [
 <xref rid="B5-molecules-25-04435" ref-type="bibr">5</xref>]. Although the incidence rate of cancer in Africa is low when compared to other continents in the world, the mortality rates are, however, higher, which significantly reflects poor therapeutic outcomes [
 <xref rid="B6-molecules-25-04435" ref-type="bibr">6</xref>].
</p>
